| |
Molecular and Cellular Pharmacology Student Seminars 2001-2002
|
Paul Nuzzi
Huttenlocher Lab
Pharmacology 901 Student Seminar
Monday, April 8, 2002
12:00 Noon
140 Bardeen
Understanding the Role of Cdc42 and Calpain in Neutrophil Chemotaxis
and Chemokinesis
Neutrophils are a class of terminally differentiated leukocytes
that comprise 60-80% of the total white blood cells circulating
in the human blood. Neutrophil chemotaxis and activation are
the first critical steps involved in innate immunity and are
essential for fighting human infection. Defects in neutrophil
response as well as chronic activation, plays a central role
in illnesses such as: ischemia-reperfusion, heart disease, arthritis
and asthma. In addition the absence of effective technology
and hyper-reactivity of neutrophils make them difficult to work
with and hard to manipulate. These obstacles have hampered our
understanding of the mechanisms that regulate neutrophil chemotaxis
and directional migration. Our lab has sought overcome these
problems by developing new techniques that will allow us to
study neutrophil chemotaxis. In order to utilize primary neutrophils,
we have established a Tat mediated "Transit Peptide System"
which allows for the introduction of full-length protein into
neutrophils. Using several purification techniques and the process
of protein conjugation we where able to demonstrate both internalization
and in vivo function of V12Cdc42. This technology in combination
with chemokinetic and chemotactic assays, allow us for the first
time to manipulate and examine morphologic and signaling changes
that occur during chemotactic migration in primary neutrophils
This allows for manipulation of chemotactic cells using an established
cell line. Recent evidence for our lab suggests that the Rho
family GTPase Cdc42 and the calcium dependent cystine protease
Calpain may play a central role in chemotactic migration. Using
these new approaches we stand poised to finally begin to decipher
and elucidate the underlying mechanisms of neutrophil chemotaxis.
References:
Allan et al. (1998) The Journal of Cell Science, Vol.141, 1147-1157
Servant et al., (1999) MBC, Vol. 10, 1163-1178
Glading et al., (2002) TCB, Vol 12, 46-54
|
|
Gerry Dodson
Tibbetts Lab
Pharmacology 901 Student Seminar
Monday, March 18, 2002
12:00 Noon
140 Bardeen
Regulation of ATR kinase activity and subcellular localization
In mammalian cells, the maintenance of genetic stability is
achieved largely through the actions of genome surveillance
mechanisms, which monitor the genome for the presence of abnormal
DNA structures, including single-stranded DNA, DNA double-strand
breaks (DSBs), and chemically modified DNA bases. Upon the detection
of damaged DNA, these genome surveillance mechanisms initiate
coordinated responses of cell cycle checkpoint activation and
DNA repair, which together serve to minimize the chance that
an incurred genetic lesion is irrevocably replicated and segregated
during mitotic cell division. Defects in the detection, signaling,
or repair of DNA damage can result in hypersensitivity to genotoxic
stress and genetic instability. The long-term research goal
of our laboratory is to define the mechanisms by which DNA damage
is recognized and converted into regulatory signals in mammalian
cells. Our studies are centered on a family of large molecular
mass protein kinases that are distantly related to the catalytic
subunit of PI3-kinase. Members of this family, including ATM
(ataxia telangiectasia-mutated) and ATR (ATM-Rad3-related) function
near the top of a genome surveillance network that initiates
cell cycle arrest, DNA repair, and transcriptional responses
in the face of genetic damage (1). Available evidence indicates
that ATM and ATR regulate common downstream pathways in response
to distinct, as well as partially overlapping forms of genotoxic
stress. Current models place ATR upstream of p53 and the protein
kinases Chk1 and Cds1, which regulate the DNA damage-activated
G1/G2 phase cell cycle checkpoints.
My research interests are focused on the mechanisms that lead
to ATR functional activation in response to genotoxic stress.
Though enhancement of ATR catalytic activity in response to
DNA damage has not been reported, the cellular localization
of ATR changes dramatically. My project currently entails mapping
the structural determinants that specify ATR localization to
nuclear foci and attempting to identify the protein(s) responsible
for targeting ATR to these subnuclear structures. Candidates
being studied now include the ATR-interacting protein (ATRIP)
identified by the Elledge group (2) as well as p130, a novel
putative ATR-associated/DNA binding protein identified by our
lab.
References:
1. Abraham, R. (2001) Cell cycle checkpoint signaling through
the ATM and ATR kinases. Genes and Development 15:2177-2196
2. Cortez, D., Guntuku, S., Qin, J., and Elledge, S.J. (2001)
ATR and ATRIP: Partners in Checkpoint Signaling. Science 294:1713-1716
|
|
Siobhan Wilson
Laboratory of Patricia J. Keely
Pharmacoloy 901 Student Seminar
Monday, March 11, 2002
12:00 Noon
140 Bardeen
Integrin-associated protein (IAP/CD47) augments the function
of 2ß1 integrin in smooth muscle cells (SMC), resulting
in enhanced chemotaxis toward soluble collagen (Wang, X-Q.,
and W.A. Frazier. 1998. Mol. Biol. Cell. 9:865). IAP-deficient
SMC derived from IAP-/- animals did not migrate in response
to 4N1K (KRFYVVMWKK), a peptide agonist of IAP derived from
the COOH-terminal domain of thrombospondin-1 (TSP1). When normal
SMC were preincubated with 4N1K or an anti- 2ß1 function-stimulating
antibody, cell migration to soluble collagen was significantly
enhanced. 4N1K-induced chemotaxis was blocked by treatment of
SMC with pertussis toxin indicating that IAP acts through Gi.
In agreement with this, 4N1K evoked a rapid decrease in c! AMP
levels which was intensified in the presence of collagen, and
forskolin and 8-Br-cAMP both inhibited SMC migration stimulated
via IAP. 4N1K strongly inhibited extracellular regulated kinase
(ERK) activation in SMC attaching to collagen and reduced basal
ERK activity in suspended SMC. Pertussis toxin treatment of
SMC significantly activated ERK, suggesting that an inhibitory
input was alleviated. Inhibition of ERK activity by (a) the
MAP kinase kinase (MEK) inhibitor, PD98059, (b) antisense oligonucleotide
depletion of ERK, and (c) expression of mitogen-activated protein
(MAP) kinase phosphatase-1 in SMC all led to increased migration
to collagen, 4N1K, or 4N1K plus collagen. Thus, IAP stimulates
2ß1 integrin-mediated SMC migration via Gi-mediated inhibition
of ERK activity an! d suppression of cyclic AMP levels. Both
of these signaling pathways could directly modulate the state
of the integrin as well as impact downstream components of the
cell motility apparatus.
Reference:
Xue-Qing Wang, Frederik P. Lindberg, and William A. Frazier
Integrin-associated Protein Stimulates 2ß1-dependent Chemotaxis
via Gi-mediated Inhibition of Adenylate Cyclase and Extracellular-regulated
Kinases
J. Cell Biol. 1999 147: 389-400.
|
Mike Gonzales
Richard Anderson Lab
Pharmacology 901 Student Seminar
Monday, March 11, 2002
12:00 Noon
140 Bardeen
Nuclear signaling by Ins(1,4,5) 3-Kinases
Inositol polyphosphate signaling begins with the creation of inositol
1,4,5 triphosphate ( Ins(1,4,5)P3) by phospholipases. Ins(1,4,5)P3
can then be acted upon by a series of kinases and phosphatases
to create a wide array of potential second messengers. The initial
phosphorylation event is mediated by a family of Ins(1,4,5)P3
3 kinases (IP3KA, IP3KB, and IP3KC) and the inositol polyphosate
multi-kanase (IPMK). IPMK can continue to perform successive phosphorylations
to create IP5 and PP-IP4, members of the family of higher inositols
that are believed to act as second messengers in cells These inositol
kinases are the initiators of higher inositol signaling and may
represent an important regulatory junction. Recent evidence suggests
that inositol polyphosphates and their associated kinases may
play a unique role in nuclear signaling. To begin to define the
role of the Ins(1,4,5)P3 in nuclear signaling we attempted to
define the subcellular localization of the Ins(1,4,5)P3 kinases.
Using polyclonal antibodies raised against full length IPMK, IP3KB,
and IP3KC we have shown that they can be detected in the nucleus.
Moreover, we have found all three localize to distinct structures
within the nucleus that also contain proteins involved in RNA
processing. Interestingly, preliminary evidence suggests that
these foci may contain additional components that may represent
an entire phosphoinosotide signaling pathway.
|
|
Akhil Bhalla
Chapman Lab
Pharmacology 901 Student Seminar
Monday, March 4, 2002
12:00 Noon
140 Bardeen
Metal Selectivity of Synaptotagmin-Membrane andSynaptotagmin-SNARE
Interactions
Physiological studies show that divalent cations other than
calcium induce secretion of neurotrasmitters form cells. The
degree of secretion (potency and efficacy) varies with the type
of metal used and also the cell type.
Our lab studies the function of Synaptotagmin and its role
in exocytosis. We believe that synaptotagmin acts as the calcium
sensor for secretion. We hypothesize that inorder for fusion
to occur, synaptotagmin must bind phospholipids and SNAREs as
a coupling step. Also, if these various metals induce secretion
they probably do it by affecting the same or similar processes
(i.e. membrane binding and SNARE binding). So we would like
to use these metals to ask whether there is any correlation
between the metal requirements for these individual steps (membrane
binding and SNARE binding) to that which is observed in physiology
(secretion from intact cells). If we see a correlation it could
mean that synaptotagmins are the sensors for those metals in
cells. If not, it could mean that there are other sensors present,
or other effector molecules that work togther with synaptotagmin.
In any case, this study will help us better understand the mechanism
by which synaptotagmin facilitates neurotrasmitter release.
The assays I will use to address these questions are membrane
penetration assays using fluorescent probes (AEDANS) and FRET.
Reference:
Ion selectivities of the calcium sensors for exocytosis in rat
phaeochromocytoma cells
Kishimoto T. et al., Journal of Physiology (2001) 533.3 pp 627-637
|
|
Haichuan Duan
Jefcoate Lab
Pharmacology 901 Student Seminar
Monday, March 4, 2002
12:00 Noon
140 Bardeen
Steroidogenic Acute Regulatory Protein
mRNA turnover mediated by the major protein-coding-region
determinant of instability (mCRD) of the c-fos proto-oncogene
transcript illustrates a functional interplay between mRNA turnover
and translation. We show that the function of mCRD depends on
its distance from the poly(A) tail. Five mCRD-associated proteins
were identified: Unr, a purine-rich RNA binding protein; PABP,
a poly(A) binding protein; PAIP-1, a poly(A) binding protein
interacting protein; hnRNP D, an AU-rich element binding protein;
and NSAP1, an hnRNP R-like protein. These proteins form a multiprotein
complex. Overexpression of these proteins stabilized mCRD-containing
mRNA by impeding deadenylation. We propose that a bridging complex
forms between the poly(A) tail and the mCRD and ribosome transit
disrupts or reorganizes the complex, leading to rapid RNA deadenylation
and decay.
Our lab is studying the Steroidogenic Acute Regulatory
Protein (StAR), a critical mediator of de novo steroid hormone
systhesis. StAR is subject to both transcriptional and post-transcriptional
regulation, the latter one being more important in the acute
phase of steoid hormone synthesis. We have evidence that StAR
message stability is coupled to ongoing translation, and several
mCRD-like elements within the StAR coding region and 3'UTR have
recently been identified, suggesting a mechanism close to c-fos
mRNA regulation.
Reference
Christophe Grosset, C.-Y. A. C., Nianhua Xu, Nahum Sonenberg,
Helene Jacquemin-Sablon, and Ann-Bin Shyu (2000). "A Mechanism
for Translationally Coupled mRNA Turnover: Interaction between
the Poly(A) Tail and a c-fos RNA Coding Determinant via a Protein
Complex." Cell 103: 29.
|
|
David Watrous-McCabe
Sheets Lab (Biomolecular Chemistry)
Pharmacology 901 Student Seminar
Monday, February 25, 2002
12:00 Noon
140 Bardeen
Understanding the Regulation of Spemann's Organizer by FGFR
Elucidating the molecular mechanisms that regulate
vertebrate development is the primary goal of the work in the
Sheets lab. In order for the normal development of a multicellular
organism to occur, cell-cell signaling events must take place
to instruct cells where to go and what to become. Spemann's
organizer is an essential inducing center in the Xenopus functioning
organizer developing embryos show reduced cell differentiation
and body axis definition. The presence of an ectopic organizer
can by itself induce secondary body axes in host tissues. Thus
showing that the signals that emanate from the organizer are
sufficient to direct development [1]. Our lab has demonstrated
that a key regulator of organizer function is the fibroblast
growth factor receptor (FGFR) signaling pathway [2]. The specific
goal of my work is to elucidate the mechanism by which FGFR
regulates signaling in the organizer, as well as to determine
how the signals that emanate from the organizer are regulated
during development. In order to elucidate the features of FGFR
responsible for downstream signaling I am using mutant receptor
constructs in the organizer and assaying organizer function.
This focus of my research will allow me to understand what properties
of FGFR mediate its ability to transduce specific signals. To
determine how signaling down stream of FGFR regulates development
I am trying to determine how the organizer specific gene chordin
is regulated. Our lab has demonstrated that FGFR is a regulator
of the transcription of chordin [2]. This provides a good starting
point from which I can determine how organizer specific genes
are regulated by FGFR.
References:
1. Gerhart, J., Evolution of the Organizer and the chordate
body plan. International Journal of Developmental Biology, 2001.
45: p. 133-153
2. Mitchell, T.S. and M.D. Sheets, The FGFR Pathway Is Required
for the Trunk-Inducing Properties of Spemann's Organizer. Developmental
Biology, 2001. 237(2): p. 295-305.
|
|
DeannaLee Beauvais
Rapraeger Lab
Pharmacology 901 Student Seminar
Monday, February 18, 2002
12:00 Noon
140 Bardeen
Syndecan-1 Adhesion Mediated Signaling in Human Breast Carcinomas
Syndecans are a family of four distinct, but homologous, type
I transmembrane cell surface heparan sulfate proteoglycans.
These receptors are expressed in all adherent cells and have
been attributed important regulatory roles in cellular differentiation,
proliferation, cell-cell/cell-matrix adhesion, cell migration
and regulation of cell morphology. Endowed by their heparan
sulfate (HS) chains, syndecans interact with components of the
extracellular matrix (ECM). Through these binding interactions,
syndecans can act as co-receptors to modify integrin-ECM adhesions,
but can also influence intracellular signaling events to elicit
changes in the cortical actin cytoskeleton. Though it is clear
that the syndecan HS chains are essential for matrix binding,
less is known about the role the syndecan core proteins play
in cell adhesion signaling. The focus of my research is to investigate
how cis protein-protein interactions of the syndecan-1 core
protein mediate the formation of macromolecular cell adhesion
and signaling complexes that regulate organization of the actin
cytoskeleton.
MDA-MB-231, a highly invasive human mammary carcinoma cell line,
endogenously express syndecan-1, -2 and -4 at their cell surface,
along with a wide complement of b1 integrins and modest levels
of the primary vitronectin receptor, avb3. These cells will
strongly adhere to a monoclonal antibody (B-B4) directed against
the extracellular domain of the syndecan-1 core protein, but
fail to spread. Though the MDA-MB-231 initially fail to spread
in response to syndecan-1 ligation, these cells can be induced
to spread in response to 1mM Mn2+ (an exogenous activator of
integrins) or with function blocking b1 integrin antibodies
(P5D2 or mAb13). This cell spreading occurs in the absence of
an integrin ligand, yet requires avb3 integrins activity as
treatment with a soluble avb3 integrin blocking antibody (LM609)
inhibits spreading. Interestingly, recent studies indicate that
cell spreading is dependent on a region located within the ectodomain
of the syndecan-1 core protein. These results suggest that anchorage
of syndecan-1 to extracellular matrix ligands initiates formation
of a syndecan-1/avb3 integrins signaling complex that mediates
reorganization of the actin cytoskeleton. Further, our results
suggest that the failure of these cells to spread in response
to syndecan-1 ligation is due to transdominant inhibition of
avb3 integrins by constitutively active b1 integrins on the
surface of these cells. This phenomenon may be a critical regulator
of invasiveness in mammary carcinoma cells.
|
|
Reema Jasuja
Greenspan Lab
Pharmacology 901 Student Seminar
Monday, February 11, 2002
12:00 Noon
140 Bardeen
Creation of a Sog Morphogen Gradient in the Drosophila Embryo
A variety of genetic evidence suggests that a gradient of decapentaplegic
(Dpp) activity determines distinct cell fates in the dorsal
region of the drosophila embryo, and that this gradient may
be generated indirectly by an inverse gradient of the BMP antagonist
Short gastrulation (Sog). It has been proposed that the Sog
diffuses dorsally from the lateral neuroectoderm where it is
produced and is cleaved and degraded dorsally by the metalloprotease
Tolloid (Tld). In this paper, it has been shown directly that
Sog is distributed in a graded fashion in dorsal cells and that
Tld degradation limits the level of Sog dorsally. In addition,
the paper discusses the dynamin dependent retrieval of Sog which
acts in parallel with degradation by Tld as a dorsal sink for
active Sog.
Reference:
Shaila Srinivasan, Kay E Rashka and Ethan Bier, Developmental
Cell, Vol.2, 91-101, Jan 2002.
|
Beth Chang
Miyamoto Lab
Pharmacology 901 Student Seminar
Monday, February 11, 2002
12:00 Noon
140 Bardeen
NFkB Activation Induced by DNA Damaging Agents: Mechanistic
Investigation of Super-induction by TPA
The transcription factor NF-kB was originally found in mature
B cells as a nuclear protein having the ability to enhance the
transcription of the k light chain gene. Since then, NF-kB has
been found in various cell types as a complex in the cytoplasm
with its inhibitor protein, IkB. IkBa degradation can be stimulated
by a variety of agents, including: pro-inflammatory molecules,
pro-oxidants, and DNA damaging agents. Inducible NF-kB activity
is initiated by degradation of its inhibitor protein, IkB. Induction
of NF-kB activity by pro-inflammatory agents is known to induce
a phosphorylation cascade. This cascade leads to a site-specific
phosphorylation of IkB by IkB kinase (IKK), followed by ubiquitination,
and 26S proteasome-mediated degradation. Free NFkB undergoes
nuclear translocation and can activate target genes with a kB
DNA binding site.
DNA damaging agents also activate PKC. A correlation between
PKC activity and NFkB activity has been demonstrated, but there
is no evidence that PKC might be modulating components in the
NFkB cascade directly.
TPA is a phorbol ester that activates NFkB. It is a very potent
tumor promoter known to activate various PKC isoforms including
PKCa, bI, bII, g, d, e, h, q and m. A short-term treatment of
TPA induces translocation of various PKCs from the cytoplasm
to the membrane where they become activated by auto-phosphorylation.
I down-regulated PKC by prolonged TPA treatment. I pre-treated
human T cells (CEMp) with TPA for 21 hours prior to the addition
of VP16 (treated for 3 additional hours). NFkB activity in the
TPA treated cells was five times higher than the cells treated
with VP16 alone despite the fact that PKCs (a, b) have been
down-regulated. This activation of NFkB is termed ìsuper-inductionî.
My research goal has been focused on determining the underlying
mechanism and functional consequence of this "super-induction"
phenomenon.
References:
1. Silverman N. and Mandates T. Genes and Development, 15:2321-2342
2. Chapman D. Pate A. Heissmeyer V and Scheidereit C. , MCB
21 (19) 6640-6650
|
|
Jared Causey
Kamp Lab
Pharmacology 901 Student Seminar
Monday, February 4, 2002
12:00 Noon
140 Bardeen
Differentiation of Embryonic Stem Cell-Derived Cardiomyocytes
(SCDCs)
The observation that embryonic stem (ES) cells, when allowed
to differentiate, produced areas of spontaneously contracting
cells has opened up a new system to study mammalian cardiac
development. Much work has been done with mouse embryonic stem
cells. However, the isolation of primate ES cell lines allows
for new studies that more closely mimic human cardiac development.
The embryoid body culture system has been widely used to produce
cardiomyocytes from mouse ES cells. In this system, spontaneous
contraction begins approximately one week after the cells begin
to differentiate. Cardiac markers (a-MHC, b-MHC, MLC-2v, etc.)
are seen to increase both from RT-PCR and immunostaining experiments.
Electrophysiological studies help to confirm the presence of
functional cardiomyocytes. Comparison to mouse fetal tissue
suggests the system's validity as a model for cardiac development.
Using a modified embryoid body system, we are currently attempting
to differentiate and characterize cardiomyocytes from human
and rhesus ES cells.
References:
Doevendans et al. Differentiation of Cardiomyocytes in
Floating Embryoid Bodies is Comparable to Fetal Cardiomyocytes.
J Mol Cell Cardiol 32:839- 851, 2000.
Kehat et al. Human Embryonic Stem Cells Can Differentiate
into Myocytes with Structural and Functional Properties of Cardiomyocytes.
J Clin Invest 108(3):407-414, 2001.
|
|
Lina Kwong
Pharmacology 901 Student Seminar
Monday, January 28, 2002
12:00 Noon
140 Bardeen
R-Ras Enhances Integrin-Mediated Signaling
to FAK and p130Cas to Promote Migration
The a2b1 integrin mediates signaling events that determine whether
an epithelial cell will polarize or migrate. Changes in a2b1
integrin expression can disrupt cell polarization, which may
lead to uncontrolled cell migration and invasion. The small
GTPase, R-Ras, has been shown to promote a2b1 integrin mediated
cell adhesion and migration in breast epithelial cells (Keely,
et al. 1999, JCB 145:1077). It is unknown how R-Ras regulates
these integrin mediated signaling events. Integrin mediated
cell migration and adhesion to the extracellular matrix involves
forming focal adhesions and signaling to molecules such as focal
adhesion kinase (FAK) and p130Cas. In human breast carcinomas,
T47D cells, we found that activated R-Ras enhanced focal adhesion
formation and the phosphorylation of FAK and p130Cas mediated
by a2b1 integrins. I will discuss the following three possible
mechanisms by which R-Ras may enhance FAK and p130Cas phosphorylation:
(1) R-Ras conformationally changes the integrin receptor to
induce higher affinity binding of ligand, (2) R-Ras clusters
integrins to increase the avidity to induce an increase in receptor
ligand binding, and (3) R-Ras activates direct signaling pathways.
Our data suggests that R-Ras enhances FAK and p130Cas phosphorylation
and focal adhesion formation by a novel mechanism that differs
from but also synergizes with the a2b1 integrin.
References:
Keely, P.J. et al., 1999. R-Ras Signals through Specific Integrin
a Cytoplasmic Domains to Promote Migration and Invasion of Breast
Epithelial Cells. JCB 145(5): 1077-1088
Giancotti, F.G. and E. Ruoslahti 1999. Integrin Signaling. Science
285: 1028-1032.
|
|
Bernice Lin
Bradfield Lab
Pharmacology 901 Student Seminar
Monday, December 17, 2001
12:00 Noon
140 Bardeen
Understanding the AhR Pathway
The aryl hydrocarbon receptor (AHR) is a prototype member of
the PAS (Per-Arnt-Sim) superfamily of proteins. In addition
to the signature PAS domain of 200 amino acids, members of this
superfamily commonly have a bHLH domain that recognizes and
binds specific DNA sequences in enhancer elements. The Aryl
Hydrocarbon Receptor (AHR) is known for its ability to mediate
toxic effects of industrial chemical byproducts such as halogenated
and polycyclic aromatics (i.e. Dioxin). The outcomes of exposure
to AHR agonists include, induction of xenobiotic metabolizing
enzymes, teratogenicity, immune suppression, tumor promotion,
and death. Despite the recognized involvement of AHR in such
effects, the causal molecular pathway to toxicity still remains
unclear. What also remains unresolved is the true physiological
role of the AHR. However, recent work on the AHR-/- does suggest
importance in hepatic vasculogenesis.
In the unliganded state, the AHR exists in the cytoplasm, bound
to a dimer of hsp90, and Ara9. Previous work has shown hsp90's
involvement with AHR to be important in maintaining the correct
conformational state for ligand binding. However, the role of
Ara9 in the AHR pathway is still unclear. It may be interacting
to stabilize AHR, or function as part of a DNA binding complex;
important in recruitment of cofactors, or may be acting to mask
the nuclear localization sequence (NLS) of the AHR; thereby
inhibiting nuclear transport. Developmentally, Ara9 is expressed
prior to, as well as in tissues distinct from AHR expression.
Therefore, Ara9 may play a role outside of the AHR pathway.
One ongoing project is creating a conditional Ara9 knockout
mouse. We hope that a knockout will shed light on the importance
of Ara9 in the AHR pathway, as well as provide insight into
other roles for the Ara9 protein in development.
Previous work in our lab gives evidence for a masked nuclear
localization signal which can be unmasked by insertions within
the a-helix at the basic region of the bHLH domain of AHR. As
previously stated, Ara9 may be responsible for masking of this
nuclear localization signal. We are working on construction
of DNA-binding mutants of the AHR by inserting alanine's at
this bHLH site and thereby rotating the helix to uncover a masking/unmasking
phenomenon. These DNA-binding mutants will also prove useful
in studying the role of AHR DNA-binding in transactivation of
genes important in either the toxic, adaptive, or endogenous
AHR pathway.
References:
1. Carver, L.A., LaPres, J.J., Jain, S., Dunham, E.E., and Bradfield,
C.A. (1998) J. Biol. Chem. 273:33580-87.
2. Gu, Y-Z, Hogenesch, J.B., and Bradfield, C.A. (2000) Annu.
Rev. Pharmacol. Toxicol. 40:519-61.
3. Petrulis, J.R., Hord, N.G., and Perdew, G.H. (2000) J. Biol.
Chem. 275:37448-53.
|
|
DeannaLee M. Beauvais
Pharmacology 901 Student Seminar
Monday, December 10, 2001
12:00 Noon
140 Bardeen
Syndecans are a family of four distinct, but homologous, type
I transmembrane cell surface heparan sulfate proteoglycans.
These receptors are expressed in all adherent cells and have
been attributed important regulatory roles in cellular differentiation,
proliferation, cell-cell/cell-matrix adhesion, cell migration
and regulation of cell morphology. Endowed by their heparan
sulfate (HS) chains, syndecans interact with components of the
extracellular matrix (ECM). Through these binding interactions,
syndecans can act as co-receptors to modify integrin-ECM adhesions,
but can also influence intracellular signaling events to elicit
changes in the cortical actin cytoskeleton. Though it is clear
that the syndecan HS chains are essential for matrix binding,
less is known about the role the syndecan core proteins play
in cell adhesion signaling. The focus of my research is to investigate
how cis protein-protein interactions of the syndecan-1 core
protein mediate the formation of macromolecular cell adhesion
and signaling complexes that regulate organization of the actin
cytoskeleton.
MDA-MB-231, a highly invasive human mammary carcinoma cell line,
endogenously express syndecan-1, -2 and -4 at their cell surface,
along with a wide complement of b1 integrins and modest levels
of the primary vitronectin receptor, avb3. These cells will
strongly adhere to a monoclonal antibody (B-B4) directed against
the extracellular domain of the syndecan-1 core protein, but
fail to spread. Though the MDA-MB-231 initially fail to spread
in response to syndecan-1 ligation, these cells can be induced
to spread in response to 1mM Mn2+ (an exogenous activator of
integrins) or with function blocking b1 integrin antibodies
(P5D2 or mAb13). This cell spreading occurs in the absence of
an integrin ligand, yet requires avb3 integrins activity as
treatment with a soluble avb3 integrin blocking antibody (LM609)
inhibits spreading. Interestingly, recent studies indicate that
cell spreading is dependent on a region located within the ectodomain
of the syndecan-1 core protein. These results suggest that anchorage
of syndecan-1 to extracellular matrix ligands initiates formation
of a syndecan-1/avb3 integrins signaling complex that mediates
reorganization of the actin cytoskeleton. Further, our results
suggest that the failure of these cells to spread in response
to syndecan-1 ligation is due to transdominant inhibition of
avb3 integrins by constitutively active b1 integrins on the
surface of these cells. This phenomenon may be a critical regulator
of invasiveness in mammary carcinoma cells.
|
Kyle McQuade
Pharmacology 901 Student Seminar
Monday, December 3, 2001
12:00 Noon
140 Bardeen
Syndecan-1 Mediated Raji Cell Spreading Requires Signaling
Through Lipid Raft
Members of the syndecan family of cell-surface transmembrane
proteoglycans play important roles in a variety of cellular
processes including growth factor signaling, cell-cell adhesion,
and the regulation of cell shape. However, the roles the syndecan
core proteins play in these processes are not well-understood.
The focus of my research is to understand the mechanism by
which syndecan-1 regulates reorganization of the actin cytoskeleton.
Raji-S1 cells, lymphoblastoid cells transfected to express
syndecan-1 as their sole proteoglycan, bind to and rapidly
spread on syndecan-1 ligands such as thrombospondin, fibronectin,
and a monoclonal antibody directed against the syndecan-1
ectodomain. Parental cells do not spread on syndecan-1 ligands.
We have expressed a panel of mutated syndecan-1 molecules
in order to assess their ability to generate a spreading response.
Truncation of the syndecan-1 extracellular or cytoplasmic
domain fails to inhibit spreading, suggesting an important
role for the syndecan-1 transmembrane. Furthermore, spreading
is blocked by methyl-beta cyclodextrin, which disrupts lipid
raft structure. Syndecan-1 is also co-isolated with known
lipid-raft markers. Taken together, these data suggest a novel
mechanism by which syndecan-1 regulates cell shape.
|
|
Erik Peden
Laboratory of Maureen Barr
Pharmacology 901 Student Seminar
Mon. Nov 26, 12pm
140 Bardeen
MAKING SENSE OF WORM SEX
All higher organisms have evolved specialized
sensory cells and receptors for perceiving selective features
of their external environment to ultimately coordinate behaviors
for survival and reproduction. While the cellular bases of sensory
systems are well characterized, less is understood about the
genes and proteins responsible for sensory detection. Our lab
is using male mating behavior of C. elegans as a model
system to study the genes, proteins and cells involved in sensory
mediated behaviors.
To identify genes required for male mating behavior,
we are undertaking a candidate gene approach and are surveying
the cellular expression profiles of all 13 C. elegans
TRP genes to see if they are expressed in male specific sex
sensory cells. This family of genes encodes 6 TM domain ion
channels, some of which have been shown to be important for
sensory behaviors in C. elegans and other organisms (1, 2).
In addition, available TRP mutant strains are being put through
behavioral assays to see if males exhibit defects in mating.
Expression data so far suggests that the TRP channels osm-9
and ocr-2 are expressed in subsets of male-specific sex
sensory cells, including spicule and ray neurons. Behavioral
data supports a role for these channels in these cells, as the
males are unresponsive to hermaphrodite contact (a ray behavior)
and are often unable to insert their copulatory spicules into
their mates' vulva.
In parallel with the candidate gene approach,
we are utilizing a forward genetics approach to clone new genes
involved in male mating. A mutant strain sy511 was originally
isolated from a mating behavior screen based on its abnormal
responsiveness to contact with hermaphrodites, and we are in
the process of mapping it genetically. It will be ultimately
cloned by cosmid rescue, which will then make it possible to
determine the molecular lesions that result in abnormal mating
behavior. By using a combination of both forward and reverse
genetic approaches, we hope to unravel the molecular basis of
sensory behaviors.
Bibliography:
1) Harteneck, C., Plant TD, and Schultz, G. From worm to man:
three subfamilies of TRP channels. TINS. 23 (4): 159-166.
2) Colbert, HA, Smith, TL, Bargmann, CI. (1997)
OSM-9, a novel protein with structural similarity to channels,
is required for olfaction, mechanosensation, and olfactory adaptation
in Caenorhabditis elegans. J Neurosci. 17 (21):8259-69.
|
Julie Sommer
Pharmacology 901 Student Seminar
Monday, November 19, 2001
140 Bardeen
|
|
Thesis Defense
P2X7 Purinergic Receptor Modulation of LPS-Stimulated Macrophage
Activation
During Gram-negative bacterial sepsis, bacterial lipopolysaccharide
(LPS, endotoxin) activates macrophages to produce a variety of
inflammatory mediators. These macrophage products are critical
in the host defense against bacterial infection, but when produced
in excessive amounts can promote lethal septic shock. Although
many of the physiological consequences of the LPS activation of
macrophages and the signal transduction pathways involved have
been defined, the exact proximal mechanisms by which LPS activates
macrophages appear to be complex and remain to be elucidated.
Extracellular adenine nucleotides, such as ATP, can be present
at high local concentrations during inflammation, and have a modulatory
role in the macrophage and host response to LPS. The exact purinergic
receptors involved were unknown until recently; however, evidence
from our laboratory and others suggests that the P2X7 receptor,
an ATP-gated ion channel, has a role in macrophage activation
by LPS.
We have observed that antagonism of the P2X7 purinergic receptor
attenuates several LPS-stimulated signal transduction events as
well as up-regulation of the inducible form of nitric oxide synthase
and the subsequent release of nitric oxide from the macrophage,
an event that requires the activation of the transcription factor
NF-kB. Because P2X7 blockade has a profound effect on LPS signaling
events, we tested the hypothesis that P2X7 activation can alone
induce some of these signal transduction pathways. It was observed
that activation of P2X7 with the selective agonist 3'-O-(4-benzoyl)benzoic
ATP (BzATP) is sufficient for activation of NF-kB in RAW 264.7
murine macrophages. In addition, BzATP, like LPS, mediates this
effect in part through the degradation of the alpha isoform of
the inhibitor of NF-kB (IkBa). Although the kinetics of LPS- and
BzATP-stimulated NF-kB activation differ, the composition of the
NF-kB complex is similar, suggesting that convergence of P2X7
and LPS-mediated pathways is possible. Further investigation utilizing
Chinese Hamster Ovary fibroblasts that stably express the LPS-binding
protein CD14 (CHO/CD14 cells) reveals that select P2X7-stimulated
signaling pathways are potentiated by CD14 expression. These observations
are consistent with the involvement of P2X7 in LPS signaling in
macrophages.
Additionally, our sequence analysis of the long cytoplasmic C-terminus
of P2X7 has revealed many potential sites for phosphorylation
and the docking of signaling and adaptor proteins, an observation
consistent with a direct role of P2X7 in signaling events apart
from its ion channel activity. Most interestingly, the extreme
C-terminus of P2X7 contains a highly conserved LPS-binding motif,
suggesting a direct interaction between P2X7 and LPS. Peptides
corresponding to this P2X7 LPS-binding motif bind LPS in vitro.
Mutation of adjacent arginine and lysine residues to glutamic
acid residues in this peptide abolish LPS binding. Based on this
observation, we were interested in determining the effect of this
mutation in the context of the whole protein. Mutant proteins
(P2X7-EE) expressed in HEK293 cells have temperature-sensitive
trafficking defects. Assessment of the function of the P2X7-EE
mutant in cells grown at the permissive temperature reveals that
BzATP-stimulated pore formation and cell death is abolished, but
that ion channel activity is intact at a reduced level. These
observations indicate that the P2X7 LPS-binding motif is important
for P2X7 protein processing as well as in the function of the
protein. The potential role of this motif in LPS signaling is
currently under investigation. In summary, these data not only
support the involvement of the P2X7 purinergic receptor in LPS-stimulated
events, but also suggest that the interaction between LPS and
the P2X7 receptor is direct.
References:
Sommer JA, Watters JJ and PJ Bertics (2001) P2X7 Receptor-Initiated
NF-kB and MAP Kinase Activation: Involvement of IkBa and the LPS-Binding
Protein CD14. (submitted).
Denlinger LC, Fisette PL, Sommer JA, Watters JJ, Prabhu U, Proctor
RA and PJ Bertics. (2001) Cutting Edge: The Nucleotide Receptor
P2X7 Contains Multiple Protein- and Lipid-Interaction Motifs Including
a Potential Binding Site for Bacterial Lipopolysaccharide.
J. Immunol. 161: 1871-1876.
Watters JJ, Sommer JA, Fisette PL, Pfeiffer ZA, Aga M, Prabhu
U, Guerra AN, Denlinger LC and PJ Bertics (2001) The P2X7 Nucleotide
Receptor: Modulation of LPS-Induced Macrophage Signaling and Mediator
Production. Drug Dev. Res. 53: 91-104.
Watters JJ, Sommer JA, Pfeiffer ZA, Prabhu U, Guerra AN and PJ
Bertics. (2001) A Differential Role for the Mitogen-Activated
Protein Kinases in LPS Signaling: The MEK/ERK Pathway Is Not Essential
For Nitric Oxide and Interleukin-1b Production. (submitted).
Sommer JA, Fisette PL, Hu Y, Denlinger LC, Guerra AN, Bertics
PJ and RA Proctor. (1999). Purinergic receptor modulation of LPS-stimulated
signaling events and nitric oxide release in RAW 264.7 macrophages.
J. of Endotoxin Res. 5(1-2):70-74.
Hu Y, Fisette PL, Denlinger LC, Guadarrama AG, Sommer JA, Proctor
RA and PJ Bertics. (1998) Purinergic Receptor Modulation of Lipopolysaccharide
Signaling and Inducible Nitric Oxide Synthase Expression in RAW
264.7 Macrophages. J. Biol. Chem. 273(42):27170-27175.
Denlinger LC, Garis KA, Sommer JA, Guadarrama AG, Proctor RA
and PJ Bertics. (1998) Nuclear Translocation of NF-kappa-B in
Lipopolysaccharide-treated Macrophages Fails to Correspond to
Endotoxicity-Evidence Suggesting a Requirement for a Gamma Interferon-Like
Signal. Inf. & Immun. 66(4):1638-164
|
Blue-leaf Hannah
Pharmacology 901 Student Seminar
Monday, November 12, 2001
140 Bardeen
12:00 Noon
Characterization of the Calcium Binding C-Terminus of Thrombospondins
Thrombospondin (TSP) 1 and 2 are members of a family of multi-modular
extracellular matrix glycoproteins that play roles in diverse
physiological and pathophysiological processes. TSP1 is released
from platelet__-granules and is expressed in atherosclerotic lesions.
Similar in structure to TSP1, TSP2 is expressed in marrow stromal
cells and fibroblasts of skin granulation tissue. Although TSP1
and TSP2 are found in pathological lesions, TSP5 is the only member
of the TSP family to be directly linked to disease. Missense mutations
localized to the C-terminal 480 residues of TSP5 result in pseudoachondroplasia
(PSACH) and multiple epiphyseal dysplasia (MED). A pathological
feature of PSACH and MED is the accumulation of mutant TSP5 in
the endoplasmic reticulum of chondrocytes. It is therefore likely
that missense mutations in this region of other TSPs could cause
similar inclusions.
The literature indicates that the calcium binding C-terminal
half of TSPs is extremely labile. In order to further understand
this lability, we chose to study TSP2. TSP2 is the only TSP with
paired cysteines, decreasing the likelihood of disulfide bond
isomerization in this region. We characterized the intrinsic fluorescence
of the calcium binding
C-terminus of human TSP2 as a function of calcium concentration.
Using a recombinant baculovirus system, we expressed E3CaG2 that
contains the last of the three EGF repeats of TSP2 (E3), the 7
aspartate-rich calcium binding (type 3) repeats (Ca), and the
globular tail (G). We also expressed the type 3 repeats alone
(Ca2), the type 3 repeats plus the globular tail (CaG2), and a
truncated version of CaG2 (tCaG2) lacking the W682 and the first
type 3 repeat. Intrinsic fluorescence of Ca2, CaG2, and tCaG2
was different from each other and markedly different from E3CaG2
suggesting that the E3 EGF repeat may modulate the calcium-dependent
conformation of the type 3 repeats. In addition, based on the
finding that the fluorescence of 6 tryptophans in the globular
tail was perturbed by calcium, we propose that E3 EGF repeat,
the type 3 repeats, and globular tail function as a single calcium-binding
unit.
|
Jianlin Chu
Pharmacology 901 Student Seminar
Monday, November 5, 2001
140 Bardeen
12:00 Noon
Abstract
The Notch pathway defines an evolutionarily conserved, cell-cell
interaction mechanism that controls an extraordinary broad spectrum
of cell fates and developmental processes. Signal transduction
through the Notch pathway is initiated when the extracellular
domain of Notch binds to its ligand on adjacent cells. Ligand
binding induces proteolytic liberation of the Notch intracellular
domain (NIC), which then translocates to the nucleus and directly
regulates gene expression. The four mammalian Notch genes,
Notch1-4, are widely expressed during embryogenesis and adult
development and play crucial roles in neurogenesis, myogenesis,
angiogenesis, hematopoiesis, renal cell development, and other
developmental processes. Mutations in the Notch receptors and
ligands are associated with human developmental disorders, indicating
the broad importance of Notch signaling in humans. However, the
molecular mechanisms underlying Notch signaling are poorly understood.
Lam LT et al. discovered that expression of constitutively
active human Notch1 (NIC-1) in human K562 erythroleukemic cells
effectively activated C-promoter binding factor1 (CBF1)-mediated
gene expression. In addition, interleukin-8 (IL-8) was strongly
induced upon hemin-induced erythroid maturation, and NIC-1 inhibited
this induction. To test the hypothesis that NIC-1 engages in crosstalk
with other cellular signaling mechanisms, we asked whether NIC-1
inhibited transcription factors required for IL-8 induction. It
was known that the IL-8 promoter is transcriptionally regulated
by AP1 and NF-_B transcription factors, both of which integrate
a diverse array of cellular signals. We found that NIC-1 inhibited
IL-8 induction by specifically repressing AP1-mediated transactivation
of IL-8; NIC-1 did not inhibit NF-_B. The CBF1-interacting RAM
domain of Notch1 was required for both NIC-1-mediated activation
of CBF1-dependent transcription and repression of AP1. Nuclear
localization was required for NIC-1-mediated repression of AP1.
To test whether NIC-1 inhibits AP1 by disrupting signaling mechanisms
necessary for AP1 activation, we assessed the phosphorylation
state of MAPK pathway components; no changes were evident. Thus,
the data are inconsistent with an anti-signaling mechanism. We
are currently testing whether inhibition involves direct antagonism
at the level of the chromatin template. Based on the importance
of AP1 target genes in hematopoiesis, vasculogenesis, and immune
cell functions such as T-cell activation, crosstalk between Notch
and AP1 pathways is likely to play previously undescribed critical
roles in the control of these processes.
|
Marty Ensenberger
Pharmacology 901 Student Seminar
October 15, 2001
140 Bardeen
Noon
Exploring the Mechanisms of Adherence and Internalization
of Streptococci: Roles for Fibronectin and Protein F1
Group A streptococci (GAS) can use several mechanisms to adhere
to and invade non-phagocytic host cells. Among these is the expression
of surface proteins that allow the bacteria to exploit a host's
own proteins and cellular machinery as a means to colonize cells.
Protein F1 (prtF1) is one such surface protein found in Streptococcus
pyogenes. PrtF1 mediates high affinity binding to fibronectin
(Fn) and facilitates S. pyogenes adherence and penetration
into cells. It acts by binding Fn with high affinity (KD ~20nM).
Once bound, Fn serves to link the bacteria to integrin receptors
found on host cells. Internalization involves proteins and processes
normally associated with focal contacts and focal adhesions. PrtF1
contains two functional Fn binding domains. We have analyzed synthetic
and recombinant versions of these domains to discover their preferred
Fn binding mode. We have also observed what seem to be structural
changes in Fn in the presence of our peptides. Our results suggest
that although prtF1 has a general affinity for type I modules
of Fn, high affinity binding to Fn is mediated by specific interactions
with N-terminal type I modules.
References:
Ozeri, V., Rosenshine, I., Ben-Ze'ev, A., Bokoch, G. M., Jou,
T., and Hanski, E. (2001) De Novo formation of focal complex-like
structures in host cells by invading Streptococci. Mol. Microbiol.
41, 1-14
Ensenberger, M. G., Tomasini-Johansson, B. R., Sottile, J., Ozeri,
V., Hanski, E., and Mosher, D. F. (2001) Specific interactions
between F1 adhesin of Streptococcus pyogenes and N-terminal modules
of fibronectin. J. Biol. Chem. 276, 35606-35613
|
Tony Huang
October 22, 2001
NF-kB activation by nuclear DNA damage: What is the
nature of the nuclear signal?
Signal transduction pathways can be modulated by the subcellular
localization of their individual components. A prototypic example
is signal-induced activation of the transcription factor NF-kB
that plays an important role in immune and inflammatory responses
and the regulation of apoptosis. In unstimulated cells, inactive
NF-kB preexists in the cytoplasm associated with its inhibitor,
IkB. Upon exposure to stimulatory signals, a series of biochemical
events targets the inhibitor protein for degradation, allowing
the release and migration of NF-kB into the nucleus to regulate
gene expression. Activation pathways of NF-kB typically originate
from the cytokine-induced ligand-receptor interactions on the
cell membrane. However, NF-kB can also be activated by a group
of agents that damage DNA in the nucleus. The nature of the nuclear
signal generated by these agents to activate cytoplasmic NF-kB
is currently unknown. We originally hypothesized that the DNA
damage-dependent signal transfer from the nucleus to the cytoplasm
involves the Crm1 nuclear export pathway. For this talk, I will
present evidence against the requirement of Crm1, but remain open
the possibility that the nuclear signal transfer might still be
mediated by an active export mechanism.
|
Jennifer Grant
Pharmacology 901 Student Seminar
Monday, October 29, 2001
140 Bardeen
Noon
Mapping the Interface Between the Transducin a-Subunit
and the cGMP Phosphodiesterase g-Subunit
Despite the extensive number of proteins known to participate
in G-protein coupled receptor signaling, relatively little is
known about the precise interactions between the protein partners.
Even the recently solved co-crystal structure (2.0 A) between
Gat-ALF4 and fragments of RGS9 and the g-subunit of the cGMP phosphodiesterase
(PDEg) leaves many unanswered questions. Namely, what are the
characteristics of PDEg interaction with Gat-GTP in isolation
, with Gat-GDP ,and what role does the N-terminal domain of PDEg
play in the regulation of vision?
Photoaffinity labeling experiments, as well as mutagenesis, provide
further insight into how PDEg binds Gat. One such experiment in
which the unique cysteine within PDEg was derivatized with a photoactive,
radioiodinated phenylazide, revealed that cys68 of PDEg lies in
close proximity to the a3 and a4/b6 regions of Gat (Liu et
al., 1996). We seek to extend our understanding of the PDEg
-binding sites on Gat. This and other experiments underscore the
important role of the PDEg C-terminus in regulating Gat.
Expanding on the cross-linking approach used by Liu et al.
(1996), I am generating full-length PDEg photoprobes containing
benzophenone for use in photoaffinity labeling experiments. Cross-linking
between PDEg photoprobe constructs and Gat will be assessed by
SDS-PAGE. Furthermore, the photoinsertion sites on Gat will be
identified by a combination of in-gel digestion and mass spectrometry.
Two proteins, Gb5 and RGS9, form an obligate heterodimer that
regulates the GTPase activity of Gat (Wei et. al, 2000).
Kinetic analysis (Skiba et al., 2001) indicates that
the combination of Gb5 and RGS9 creates a complex that specifically
recognizes PDEg -laden GatGTP. Cross-linking experiments with
a variety of PDEg benzophenone photoprobes will clarify the 3-dimensional
interactions of PDEg with each of these proteins.
In collaboration with the Markley research group, NMR experiments
are underway to determine structural changes that affect PDEg
upon binding Gat. In particular, heteronuclear single quantum
coherence (HSQC) experiments suggest there is some secondary structure
to the PDE C-terminus even in the absence of Gat. Similarly, NMR
techniques will be employed to define structural changes affecting
PDEg as Gat binds.
References:
Liu, Y., Arshavsky, V.Y., and Ruoho, A.E. (1996) J. Biol.
Chem.. 271: 26900-26907.
Skiba NP, Martemyanov KA, Elfenbein A, et al. (2001)
J. Biol. Chem. 276 : 37365-37372.
Slep KC, Kercher MA, He W, et al. (2001) Nature
409: 1071-1077.
Wei, H., Lu, L., Zhang, X.El-Hodiri, H., Chen, C.-K., Slep,
K.C., Simon, M.I., Jamrich, M., Wensel, T.G. (2000) J. Biol.
Chem. 275:37093-37100.
|
|